Vorapaxar. PAR1 receptor antagonist, antiplatelet therapy

S. Goto, V. Serebruany

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Vorapaxar. PAR1 receptor antagonist, antiplatelet therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences